UnknownPhase 4NCT05119426
Effectiveness of a Typhoid Conjugate Vaccine in DRC
Studying Typhoid
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- International Vaccine Institute
- Principal Investigator
- Florian Marks, PhD, LMFT, LPCCUniversity of Cambridge
- Intervention
- Vi-TT(biological)
- Enrollment
- 48000 enrolled
- Eligibility
- 15 years · All sexes
- Timeline
- 2022 – 2024
Study locations (25)
- Cerphytoco, Kisantu, Bas-Congo Province, Democratic Republic of the Congo
- CS Cederi Madimba, Kisantu, Bas-Congo Province, Democratic Republic of the Congo
- CS Kavuaya, Kisantu, Bas-Congo Province, Democratic Republic of the Congo
- CS Kilenda, Kisantu, Bas-Congo Province, Democratic Republic of the Congo
- CS Kimuisi, Kisantu, Bas-Congo Province, Democratic Republic of the Congo
- CS Kinkonko, Kisantu, Bas-Congo Province, Democratic Republic of the Congo
- CS Kintanu Etat, Kisantu, Bas-Congo Province, Democratic Republic of the Congo
- CS Kipako, Kisantu, Bas-Congo Province, Democratic Republic of the Congo
- CS Kipasa, Kisantu, Bas-Congo Province, Democratic Republic of the Congo
- CS Kivuangi, Kisantu, Bas-Congo Province, Democratic Republic of the Congo
- CS Lemfu, Kisantu, Bas-Congo Province, Democratic Republic of the Congo
- CS Ngeba, Kisantu, Bas-Congo Province, Democratic Republic of the Congo
- CS Saint Pierre Boko, Kisantu, Bas-Congo Province, Democratic Republic of the Congo
- CS Yimbi, Kisantu, Bas-Congo Province, Democratic Republic of the Congo
- Gare, Kisantu, Bas-Congo Province, Democratic Republic of the Congo
- +10 more locations on ClinicalTrials.gov
Collaborators
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo · University of Cambridge · Institute of Tropical Medicine, Belgium
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05119426 on ClinicalTrials.govOther trials for Typhoid
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT04083950Induction of Gut Permeability by an Oral VaccineUSDA, Western Human Nutrition Research Center
- ACTIVE NOT RECRUITINGPHASE3NCT03299426Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, MalawiUniversity of Maryland, Baltimore
- ACTIVE NOT RECRUITINGPHASE4NCT03970304CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated AdultsUniversity of Maryland, Baltimore